Non-steroidal anti-inflammatory ligands

Phenylbutazone(diphenyl-d 10 ) is the deuterium labeled Phenylbutazone. Phenylbutazone is an efficient reducing cofactor for the peroxidase activity of prostaglandin H synthase (PHS). Phenylbutazone, a hepatotoxin, is a nonsteroidal

Phenylbutazone(diphenyl-d 10 ) is the deuterium labeled Phenylbutazone. Phenylbutazone is an efficient reducing cofactor for the peroxidase activity of prostaglandin H synthase (PHS). Phenylbutazone, a hepatotoxin, is a nonsteroidal

polmacoxib.

polmacoxib.

Rintodestrant (G1T48) is an orally active, non-steroidal and selective estrogen receptor degrader. Rintodestrant (G1T48) is also a CDK4/6 inhibitor.In VitroRintodestrant (G1T48) is a potent and efficacious inhibitor of estrogen-mediated

Rintodestrant (G1T48) is an orally active, non-steroidal and selective estrogen receptor degrader. Rintodestrant (G1T48) is also a CDK4/6 inhibitor.In VitroRintodestrant (G1T48) is a potent and efficacious inhibitor of estrogen-mediated

Rintodestrant (G1T48) is an orally active, non-steroidal and selective estrogen receptor degrader. Rintodestrant (G1T48) is also a CDK4/6 inhibitor.In VitroRintodestrant (G1T48) is a potent and efficacious inhibitor of estrogen-mediated

Topilutamide is a topical nonsteroidal antiandrogen (NSAA).In VivoProstate cancer is the most common cancer and one of the leading causes of cancer deaths in men. One of the commonly used approaches to treat metastatic prostate cancer is via

Topilutamide is a topical nonsteroidal antiandrogen (NSAA).In VivoProstate cancer is the most common cancer and one of the leading causes of cancer deaths in men. One of the commonly used approaches to treat metastatic prostate cancer is via

Topilutamide is a topical nonsteroidal antiandrogen (NSAA).In VivoProstate cancer is the most common cancer and one of the leading causes of cancer deaths in men. One of the commonly used approaches to treat metastatic prostate cancer is via

Topilutamide is a topical nonsteroidal antiandrogen (NSAA).In VivoProstate cancer is the most common cancer and one of the leading causes of cancer deaths in men. One of the commonly used approaches to treat metastatic prostate cancer is via

Topilutamide is a topical nonsteroidal antiandrogen (NSAA).In VivoProstate cancer is the most common cancer and one of the leading causes of cancer deaths in men. One of the commonly used approaches to treat metastatic prostate cancer is via